A clinical formulation indicated for Bladder and Urinary. Promotes fluid balance by reducing excessive urine production and supports better sleep continuity.
Designed to mitigate excessive nighttime urine production to alleviate frequent bathroom trips and support uninterrupted sleep cycles in adult patients with nocturia.
Mechanism of Action
Desmopressin mimics a natural hormone that tells the kidneys to reabsorb water back into the body. By reducing the volume of urine produced during the night, it helps patients sleep longer before needing a bathroom.
Route of Administration
Sublingual
Onset Time
30–60 minutes
Duration
6–8 hours
Contraindications
Hyponatremia, Moderate to severe renal impairment, Heart failure, Polydipsia (excessive thirst), SIADH
Severe Adverse Events
Severe hyponatremia leading to seizures, Water intoxication, Coma, Heart rhythm changes, Severe allergic reactions
Information for Nocdurna is sourced from established medical standards and updated frequently. It is provided for general reference and should be confirmed with a healthcare professional before use.
